...
首页> 外文期刊>Diagnostic microbiology and infectious disease >Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America).
【24h】

Epidemiology and frequency of resistance among pathogens causing urinary tract infections in 1,510 hospitalized patients: a report from the SENTRY Antimicrobial Surveillance Program (North America).

机译:在1,510例住院患者中,引起尿路感染的病原体的流行病学和耐药频率:来自SENTRY抗菌药物监测计划(北美)的报告。

获取原文
获取原文并翻译 | 示例
           

摘要

Bacterial urinary tract infections (UTIs) are an important cause of septicemia resulting in high mortality rates, prolonged hospital stays and increased healthcare costs. Periodic reviews of pathogen frequency and susceptibility patterns impact on appropriate antimicrobial usage, leading to more effective prescribing practices. As part of the SENTRY Antimicrobial Surveillance Program (SENTRY, 1998), participants collected 50 consecutive UTI pathogens from patients hospitalized in 31 medical centers (26 in the United States and five in Canada) and forwarded subcultures to the coordinating center. Thirty-four antimicrobial agents were tested including two investigational compounds (quinupristin/dalfopristin [Q/D], gatifloxacin). The rank order of the 32 species identified during the study was: Escherichia coli (46.9%) > Enterococcus spp. (12.8%) > Klebsiella spp. (11.0%) > Pseudomonas aeruginosa (7.5%) > Proteus mirabilis (5.0%) > coagulase-negative staphylococci (CoNS; 3.4%). This pathogen rank order did not change from 1997 to 1998, but resistance patterns changed. Clonal spread of confirmed extended spectrum beta-lactamase-producing strains was not observed, but co-resistance was elevated for aminoglycosides, tetracyclines, sulfonamides, and fluoroquinolones. P. aeruginosa was most susceptible to amikacin (97.3%) > piperacillin +/- tazobactam (92.0-95.6%) > cefepime = imipenem (91.2%) > ceftazidime (85.8%). Fluoroquinolone resistance was greater in P. aeruginosa (24.8-39.8%) > P. mirabilis (5.3-13.3%) > Enterobacter spp. (6.7-8.9%) > Klebsiella spp. (4.2-7.8%) > E. coli (3.0-3.8%). Only 5% of enterococci were resistant to vancomycin. These results emphasize the need for continued surveillance studies for common infections which establish baseline resistance patterns by geographic areas, and have the potential to detect epidemics or direct local epidemiologic interventions.
机译:细菌性尿路感染(UTI)是败血症的重要原因,导致高死亡率,延长住院时间和增加医疗费用。定期检查病原体的频率和敏感性模式会影响适当的抗菌药物使用,从而导致更有效的处方操作。作为SENTRY抗菌素监测计划(SENTRY,1998)的一部分,参与者从31个医疗中心(美国的26个和加拿大的5个)住院的患者中收集了50种连续的UTI病原体,并将亚培养转发给协调中心。测试了34种抗菌剂,其中包括两种研究化合物(奎奴普丁/达福普汀[Q / D],加替沙星)。在研究中确定的32个物种的等级顺序是:大肠杆菌(46.9%)>肠球菌。 (12.8%)>克雷伯菌属(11.0%)>铜绿假单胞菌(7.5%)>变形杆菌(5.0%)>凝固酶阴性葡萄球菌(CoNS; 3.4%)。从1997年到1998年,这种病原体的等级顺序没有变化,但是耐药性发生了变化。没有观察到证实的产生广谱β-内酰胺酶的菌株的克隆传播,但是对氨基糖苷类,四环素类,磺酰胺类和氟喹诺酮类药物的抗药性有所提高。铜绿假单胞菌最容易受到丁胺卡那霉素(97.3%)>哌拉西林+/-他唑巴坦(92.0-95.6%)>头孢吡肟=亚胺培南(91.2%)>头孢他啶(85.8%)。铜绿假单胞菌(24.8-39.8%)>奇异假单胞菌(5.3-13.3%)>肠杆菌属的细菌对氟喹诺酮的耐药性更高。 (6.7-8.9%)>克雷伯菌属(4.2-7.8%)>大肠杆菌(3.0-3.8%)。只有5%的肠球菌对万古霉素耐药。这些结果强调需要对常见感染进行持续的监测研究,这些研究可以按地理区域确定基线耐药性模式,并且有可能发现流行病或直接进行当地流行病学干预。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号